Skip to main content
HR 2869 117th Congress House Health Congressional oversight Government studies and investigations Health care costs and insurance Medicare Prescription drugs

Increasing Access to Biosimilars Act of 2021

Introduced: April 28, 2021 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 29, 2021
Referred to the Subcommittee on Health.
Apr 28, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 28, 2021
Referred to the Subcommittee on Health.
Apr 28, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Increasing Access to Biosimilars Act of 2021

This bill requires the Centers for Medicare & Medicaid Services to establish a demonstration project to evaluate the benefits of providing additional payments to providers of biosimilars under Medicare. Specifically, under the demonstration project, participating providers receive an additional payment based on the difference between the costs to the provider of furnishing the biosimilar and the cost if the provider had furnished the underlying reference biological product instead.

What's happening now April 29, 2021

Referred to the Subcommittee on Health.

 Related & companion bills 1
  • S 1427 Related bill Increasing Access to Biosimilars Act of 2021
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 2
All 2 Democratic 2
D
Blunt Rochester, Lisa
Delaware · May 11, 2021
 D
Craig, Angie
Minnesota · Apr 28, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2869: Increasing Access to Biosimilars Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-2869/
MLA
"H.R. 2869: Increasing Access to Biosimilars Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-2869/.
Bluebook (legal)
H.R. 2869, 117th Cong. (2026), https://openamerica.io/bill/117-HR-2869/.
Markdown link
[H.R. 2869: Increasing Access to Biosimilars Act of 2021](https://openamerica.io/bill/117-HR-2869/)
Report a problem